Skip to content
HowShorted

ALDER BIOPHARMACEUTICALS INC short interest in 2019

In 2019, ALDER BIOPHARMACEUTICALS INC's disclosed short interest ran from 18.28% of shares outstanding on 15 Jan 2019 to 11.28% on 15 Oct 2019, a change of -7.00 percentage points. The year's high was 20.12% on 28 Feb 2019 and its low 11.28% on 15 Oct 2019, averaging 17.75% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.68 days on 30 Aug 2019. Full history: ALDER BIOPHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019

Aggregate net short position time series for ALDER BIOPHARMACEUTICALS INC in 2019

2019 in figures

Start of year
18.28% (15 Jan 2019)
End of year
11.28% (15 Oct 2019)
Change
-7.00 pp
High
20.12% (28 Feb 2019)
Low
11.28% (15 Oct 2019)
Average
17.75%
Highest days to cover
31.68 (30 Aug 2019)
SEC filings marked
6

Every report in 2019

ALDER BIOPHARMACEUTICALS INC short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201918.28%10.69
31 Jan 201919.40%8.62
15 Feb 201919.58%17.89
28 Feb 201920.12%8.9310-K filed, results (8-K)
15 Mar 201918.93%12.76
29 Mar 201918.86%16.90
15 Apr 201919.18%13.91
30 Apr 201915.72%12.72
15 May 201916.91%11.4010-Q filed, results (8-K)
31 May 201916.19%16.57
14 Jun 201915.89%20.84
28 Jun 201918.45%12.00
15 Jul 201917.96%21.93
31 Jul 201918.17%17.28
15 Aug 201918.82%22.3010-Q filed, results (8-K)
30 Aug 201919.18%31.68
13 Sep 201919.88%23.25
30 Sep 201914.41%1.22
15 Oct 201911.28%2.50

See also: ALDER BIOPHARMACEUTICALS INC's full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.